Traynor Capital Management, Inc.

Position in BCLI — Brainstorm Cell Therapeutics Inc.

CIK 1666786 MALVERN, PA

Position in BCLI

as of Jun 30, 2025 · filed Aug 7, 2025 Compact

Position Value

$12,320

New position

Shares Held

11,000

first reported quarter

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Traynor Capital Management, Inc. holds $9,749,803 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	9,049	$4,494,909
2	ALNY	Alnylam Pharmaceuticals, Inc.	10,458	$3,148,171
3	REGN	Regeneron Pharmaceuticals, Inc.	3,005	$1,873,737
4	IBRX	ImmunityBio, Inc.	19,200	$168,096
5	NGEN	Nervgen Pharma Corp.	31,500	$64,890

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-06-30	$12,320	11,000	—	Shares	Sole	2025-08-07
No filing history on record for this holder in this stock.